A longer duration of lactation (> 6 months) is associated with lower odds of non-alcoholic fatty liver disease (NAFLD) in mid-life women and may represent a modifiable risk factor for NAFLD, a recent study found. Participants from the Coronary Artery Risk Development in Young Adults cohort study who delivered ≥1 child post-baseline and underwent CT quantification of hepatic steatosis 25 years following cohort entry were included. Among the findings:
- Of 844 women who delivered after baseline, 32% reported lactation duration 0 to 1 month, 25% reported >1 to 6 months, 43% reported >6 months, while 54 (6% had NAFLD.
- Lactation duration >6 months was protective against NAFLD in mid-life after adjustment for confounders.
- The benefits of increased lactation duration on weight and waist circumference mediated < one-fourth of this benefit.
Ajmera VH, Terrault NA, VanWagner LB, et al. Longer lactation duration is associated with decreased prevalence of non-alcoholic fatty liver disease in women. [Published online ahead of print November 1, 2018]. J Hepatol. doi:10.1016/j.jhep.2018.09.013.
This Week's Must Reads
Hospital Colectomy Volume & Complications, Clin Gastroenterol Hepatol; ePub 2019 Mar 7; Egberg, et al
Esophageal & Gastric Cancer Subtypes by Race, Clin Gastroenterol Hepatol; 2019 Feb; Islami, et al
Assessing Quality of Life in Patients with Inflammatory Bowel Disease, Am J Gastroenterol; ePub 2019 Mar 1; Barnes, et al
Must Reads in Endoscopy, Pancreas, & Biliary Tract
Gender Differences in Patients Hospitalized with Cirrhosis, J Clin Gastroenterol; ePub 2019 Feb 22; Rubin, et al
POC Test for Identifying Viraemic HCV Infection, J Hepatol; ePub 2019 Feb 21; Freiman, et al
Frailty in Patients with Ascites & Hepatic Encephalopathy, Gastroenterology; ePub 2019 Jan 19; Lai, et al
Hypercholesterolemia & Statin Exposure in Cirrhosis, Gastroenterology; ePub 2019 Jan 18; Kaplan, et al
Response to UDCA Treatment in PBC Patients, Clin Gastroenterol Hepatol; ePub 2019 Jan 4; Cheung, et al